Ronald Degarmo
Family Medicine · Greer, SCNPI 1316961865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $807 and has fallen 97.8% since, to $18 in 2025.
Across 106 payments — averaging $13.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$333
- AbbVie$220
- Mylan Specialty L.p.$179
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$171
- Supernus Pharmaceuticals, Inc.$135
- Astellas Pharma US Inc$54
- plus $364 from 19 others
Across 48 payments — averaging $3877.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$79K
- Pfizer$54K
- AstraZeneca$23K
- Amgen$12K
- Kowa Research Institute, Inc.$10K
- GSK$7K
- plus $2K from 1 others
What the payments were for
- Food & beverage$1,44199%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $333 |
| AbbVie(2 entities) | 22 | $220 |
| Mylan Specialty L.p. | 12 | $179 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $171 |
| Supernus Pharmaceuticals, Inc. | 11 | $135 |
| Astellas Pharma US Inc | 4 | $54 |
| AstraZeneca | 3 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Amgen | 2 | $32 |
| Novartis | 2 | $29 |
| Antares Pharma, Inc. | 2 | $25 |
| Orexo US, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Promius Pharma LLC | 1 | $11 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLOGUARD$112
How this compares
$1,457 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Greer
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.